None listed
Conditions
Brief summary
Patients will be recruited and randomly assigned to one of two treatment groups. Treatment group 1 will receive CPAP with a heated humidification Treatment group B will receive CPAP with heated humidification delivered via a heated breathing tube Duration: 12 months Patient compliance, quality of life and side effects of CPAP treatment will be assessed.
Interventions
Treatment group B will receive Continuous Positive Airway Pressure (CPAP) with heated humidification delivered via a heated breathing tube Dose: Pressure for each patient will be determined via a overnight polysomnography, pressure is increased until there is no longer any sleep disordered breathing or a apnea hypopnea index less than 5. Pressure range will be between 4cmH20 and 20cmH20. Duration: Subjects will use treatment at a dose prescribed to treat sleep disordered breathing every time the patient sleeps for 12 months. There is no strict number of hours that the patient is required to sleep with the device, patients will use the device at each sleep session for as long as they can tolerate optimally until they awake in the morning. Range of hours will be between 0 and 12 hours usage.
Sponsors
Study design
Eligibility
Inclusion criteria
Newly diagnosed sleep apnoea syndrome. Apnea hypopnea index (AHI) > 5/hr, accompanied by clinical symptoms of sleep apnoea. Written consent.
Exclusion criteria
No consent givenCerebral disordersPeriodic Leg Movement Syndrome (PLMS) during sleepExacerbated chronic obstructive respiratory illnessesDecompensated heart insufficiencyMalignant heart arrhythmia or uncontrolled arterial hypertoniaPregnancyMalignant illnesses.